Company Overview
| Stock Name | Glory Health |
|---|---|
| Stock Code | 02329 |
| Company Full Name | To be extracted |
| Industry | 房地产 |
| Principal Activities | 我們是中國一家高速成長的住宅物業開發商,並兼營商業物業業務。主要經營中國的住宅項目以及大型多用途綜合體項目,同時選擇性地保留優質商業物業作為租金來源,並承建一級土地開發項目以取得土地儲備。 |
| Listing Date | 2014-07-07 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 北京市東城區珠市口東大街15號 |
| Business Address (Hong Kong) | 香港港灣道18號中環廣場51樓5103A室 |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | www.glorypty.com |
| Share Registrar | 香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 2.38 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | 2014-06-23 to 2014-06-26 |
| Global Offering Shares | 661,780,000 shares |
| HK Public Offer Shares (Initial) | 66,178,000 shares (10.0%) |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | 595,602,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 4,411,780,000 shares |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | To be extracted |
| Cornerstone Share | 6.3% |
| Clawback Tiers | To be extracted |
| Reallocation Option | No |
| Total Global Offering Size | HK$ 1,575,036,400 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| Avg Daily HK Mkt Cap | HK$ 465.9M |
| Est. Threshold | HK$ 9.71B |
| Analysis Result | HK market cap below threshold, need +1985% |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 盈利約人民幣2,770.2百萬元 |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
RMB
Income Statement
| Item | 2011 | 2012 | 2013 |
|---|---|---|---|
| Revenue | 1,753,398 | 4,275,996 | 6,835,358 |
| Cost of sales | -955,157 | -2,700,448 | -3,130,684 |
| Gross profit | 798,241 | 1,575,548 | 3,704,674 |
| Other income and gains, net | 11,061 | 56,697 | 8,426 |
| Selling and distribution expenses | -148,134 | -108,131 | -184,545 |
| Administrative expenses | -226,433 | -282,839 | -242,269 |
| Net finance costs | -192,970 | -230,039 | -572,542 |
| Share of associates and JVs | 11 | -65 | 0 |
| Profit before tax | 1,075,107 | 2,033,649 | 3,855,784 |
| Income tax expense | -330,686 | -760,471 | -1,085,595 |
| Profit for the year | 744,421 | 1,273,178 | 2,770,189 |
| Profit attributable to owners | 597,001 | 1,029,776 | 2,233,812 |
Balance Sheet
| Item | 2011 | 2012 | 2013 |
|---|---|---|---|
| Cash and cash equivalents | 589,266 | 803,373 | 844,854 |
| Trade and bills receivables | 1,580,914 | 556,680 | 389,494 |
| Inventories | 6,833 | 8,145 | 93 |
| Total current assets | 13,721,754 | 11,379,926 | 14,267,765 |
| Total assets | 20,284,796 | 18,792,611 | 22,467,403 |
| Total current liabilities | 10,069,020 | 8,283,901 | 8,451,791 |
| Total liabilities | 15,690,031 | 13,107,113 | 16,371,424 |
| Total equity | 4,594,765 | 5,685,498 | 6,095,979 |
| Equity attributable to owners | 3,802,056 | 4,898,733 | 4,788,414 |
| Interest-bearing borrowings | 5,623,867 | 5,682,780 | 7,336,560 |
Cash Flow Statement
| Item | 2011 | 2012 | 2013 |
|---|---|---|---|
| Net cash from operating activities | -1,531,172 | 37,675 | 32,901 |
| Net cash from investing activities | -232,316 | -502,183 | 355,037 |
| Net cash from financing activities | 1,126,389 | 678,615 | -346,457 |
| Net increase in cash | -637,099 | 214,107 | 41,481 |
| Depreciation of PP&E | 22,907 | 22,973 | 23,732 |
| Amortisation of intangible assets | 603 | 818 | 579 |
| Purchase of PP&E | -13,178 | -54,490 | -18,897 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 2.5 |
|---|---|
| First Day Open | HK$ 2.32 |
| First Day Change | 5.04% |
| First Day Volume | 6447000.0 |
| First Day Turnover | 16288600.0 |
| Use of Proceeds | 1、約60%或約889.6百萬港元預期用于我們的物業開發項目,其中:
a.約40%或約593.1百萬港元預期用于開發北京國瑞中心、沈陽國瑞城四期、海闊天空國瑞城四及五期項目,包括高層及超高層地標性甲級寫字樓;
b.其余20%或約296.5百萬港元預期用于我們的其他物業開發項目,包括開發鄭州國瑞城六期及永清國瑞城四期;
2、約30%或約444.8百萬港元預期用于未來在我們目前經營所在城市和目標城市,特別是珠江三角洲,物色和收購合適的地塊作為我們的土地儲備;
3、其余10%或約148.3百萬港元將作我們的一般企業及營運資金用途。
|
Underwriting Syndicate
Sole Sponsor (1)
BOCI ASIA LIMITED CE AET863
Overall Coordinators (1)
BOCI ASIA LIMITED CE AET863
Joint Bookrunners (2)
Joint Lead Managers (2)
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Best Class Industrial Limited | 143,540,180 HKD | — | 1.37% | — | 6 months | 2015-01-07 |
| 2 | 北京市第五建筑工程集团有限公司 | 233,368,520 HKD | — | 2.22% | — | 6 months | 2015-01-07 |
| 3 | 中国生物制药有限公司 | 287,080,360 HKD | — | 2.73% | — | 6 months | 2015-01-07 |
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 張章笋 | — |
| Company Secretary | 鄭瑾、鄺燕萍 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 張主席透過通和持有3,716,382,300股股份,佔全球發售完成後已發行股本約84.238% |
|---|




